A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

Clinical trial NCT07218770 · TERMINATED

Trial details

NCT number: NCT07218770
Sponsor: Regeneron Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Active Noninfectious Uveitis Affecting the Posterior Segment

Start date: 2025-12-17
Primary completion: 2026-07-21
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.